MediPal Holdings Corporation Stock Other OTC
Equities
MAHLY
US58502T1079
Pharmaceuticals
Sales 2024 * | 3,527B 22.82B | Sales 2025 * | 3,561B 23.04B | Capitalization | 521B 3.37B |
---|---|---|---|---|---|
Net income 2024 * | 35.7B 231M | Net income 2025 * | 35.68B 231M | EV / Sales 2024 * | 0.15 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.15 x |
P/E ratio 2024 * |
14.7
x | P/E ratio 2025 * |
14.9
x | Employees | - |
Yield 2024 * |
2.42% | Yield 2025 * |
2.52% | Free-Float | 84.27% |
Managers | Title | Age | Since |
---|---|---|---|
Shuichi Watanabe
PSD | President | 72 | 00-03-31 |
Midori Ito
CMP | Compliance Officer | - | - |
Takeshi Yanagida
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Shuichi Watanabe
PSD | President | 72 | 00-03-31 |
Toshihide Yoda
BRD | Director/Board Member | 61 | 10-05-31 |
Director/Board Member | 69 | 77-03-31 |
1st Jan change | Capi. | |
---|---|---|
+15.21% | 70.09B | |
-2.19% | 24.01B | |
+8.13% | 8.32B | |
-18.28% | 8.23B | |
0.00% | 8.08B | |
+19.12% | 4.41B | |
0.00% | 4.12B | |
-3.02% | 3.88B | |
+23.97% | 3.71B |